Solace secures funding to enhance healthcare advocacy services.
Want to target the right audience? Sponsor our site and choose your specific industry to connect with a relevant audience.
Prominent brand mentions across targeted, industry-focused articles
High-visibility placements that speak directly to an engaged local audience
Guaranteed coverage that maximizes exposure and reinforces your brand presence
Interested in seeing what sponsored content looks like on our platform?
May’s Roofing & Contracting
Forwal Construction
NSC Clips
Real Internet Sales
Suited
Florida4Golf
Click the button below to sponsor our articles:
Sponsor Our ArticlesHealthcare startup Solace has achieved an over $300 million valuation after a successful Series B funding round led by Menlo Ventures. Founded in 2022 by Jeremy Gurewitz and Sara Sargent, Solace aims to assist patients with navigating healthcare challenges by connecting them directly with healthcare advocates. With plans to raise an additional $40 million, Solace is positioned to expand its services and further support Medicare patients in accessing necessary healthcare resources and advocacy.
In an exciting development for the world of healthcare innovation, Solace, a fresh-faced startup founded just last year, has locked in a whopping over $300 million valuation following a successful funding round led by Menlo Ventures. As part of its Sweet Series B journey, Solace is aiming to snag another $40 million to further its mission of helping patients navigate the often tangled web of healthcare woes.
Launched in 2022 by dynamic duo Jeremy Gurewitz, who holds the title of CEO, and Sara Sargent, the company’s CPO, Solace has swiftly established itself as a true game-changer in healthcare. The startup’s innovative model connects patients directly with healthcare advocates, helping them tackle everything from scheduling those daunting appointments to appealing pesky insurance denials.
Solace is particularly beneficial for Medicare patients, connecting them with a team of former healthcare professionals including doctors, nurses, and pharmacists from coast to coast. With access to support covering over 100 conditions, including autoimmune diseases and chronic conditions, thousands of individuals can find the guidance they desperately need.
Interestingly, just last year, Medicare expanded its coverage to include patient advocacy services, a timely development that leaves Solace in prime position as it rides the wave of growing demand.
By early 2025, Solace boasted an impressive $10 million revenue run rate. Prior to the current Series B funding, the young startup had already raised $21 million through earlier investments, including a notable $14 million in Series A funding that kicked off in August 2023, led by Inspired Capital.
While Solace is busy raking in substantial financial backing, it’s not just about the cash. The startup’s services are not only federally covered under Medicare, but many Medicare Advantage plans also foot the bill for Solace’s offerings, often at little to no expense for patients. This means that those who find themselves lost in the healthcare maze can access expert help without financial strain.
So, what exactly do these savvy healthcare advocates do? They can manage doctor’s appointments, ensure smooth continuity of care, maximize insurance benefits, and handle all that frustrating paperwork that often overwhelms patients. Solace even offers its own Electronic Health Record (EHR) system so advocates can easily manage and access medical records.
Solace uses a unique proprietary matching algorithm to connect patients with the most suitable advocates, which explains their impressive 96 Net Promoter Score—a clear indication of customer satisfaction. Their interactive platform allows patients to engage in real-time with their advocates, creating a seamless experience that’s both personal and effective.
In a healthcare landscape that has faced growing scrutiny, especially in the wake of events such as the tragic murder of a prominent healthcare CEO, healthcare startups like Solace are emerging as beacons of hope. While many companies are scrambling to simplify the complexities of the health system, few are placing patients at the forefront like Solace does.
The funds from this much-anticipated Series B round will be used to further develop the platform, expand the network of advocates, and broaden coverage with Medicaid and private insurers. The ambitious founders of Solace are on a mission to not just assist patients but entirely redefine the healthcare landscape in the U.S., making healthcare advocacy more accessible and effective for everyone.
So, here’s to hoping Solace continues on its shiny, upward trajectory—because when it comes to healthcare, everyone could use a little more Solace.
March Celebrates Social Work Month: A Tribute to Social Workers
News Summary A couple from Michigan, Paul and Christy Akeo, faces legal troubles in Cancun…
News Summary The Michigan Department of Agriculture and Rural Development (MDARD) has announced the allocation…
News Summary Michigan is confronting a severe food crisis as food banks prepare for imminent…
News Summary Following the tragic death of 5-year-old Thomas Cooper in a hyperbaric oxygen chamber…
News Summary Michigan is experiencing the highest increase in unemployment rates in the nation, rising…
News Summary Fortune has released its 2025 list of America's Most Innovative Companies, with Alphabet…